BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Z, Yu W, Qiang Y, Xu L, Ma F, Ding P, Shi L, Chang W, Mei Y, Ma X. LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression. Mol Ther Oncolytics 2020;17:547-61. [PMID: 32637573 DOI: 10.1016/j.omto.2020.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Shi Y, Zhang DD, Liu JB, Yang XL, Xin R, Jia CY, Wang HM, Lu GX, Wang PY, Liu Y, Li ZJ, Deng J, Lin QL, Ma L, Feng SS, Chen XQ, Zheng XM, Zhou YF, Hu YJ, Yin HQ, Tian LL, Gu LP, Lv ZW, Yu F, Li W, Ma YS, Da F. Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma. Mol Ther Nucleic Acids 2021;23:702-18. [PMID: 33575116 DOI: 10.1016/j.omtn.2020.12.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Xu LF, Shi L, Zhang SS, Ding PS, Ma F, Song KD, Qiang P, Chang WJ, Dai YY, Mei Y, Ma XL. LukS-PV Induces Apoptosis via the SET8-H4K20me1-PIK3CB Axis in Human Acute Myeloid Leukemia Cells. Front Oncol 2021;11:718791. [PMID: 34745943 DOI: 10.3389/fonc.2021.718791] [Reference Citation Analysis]
3 Cheng B, Zhou P, Chen Y. Machine-learning algorithms based on personalized pathways for a novel predictive model for the diagnosis of hepatocellular carcinoma. BMC Bioinformatics 2022;23:248. [PMID: 35739471 DOI: 10.1186/s12859-022-04805-9] [Reference Citation Analysis]
4 Xu X, Ding P, Shi L, Wu G, Ma X. LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. BMC Cancer 2022;22:630. [PMID: 35676659 DOI: 10.1186/s12885-022-09680-4] [Reference Citation Analysis]
5 Nie Z, Shi L, Song K, Xu X, Ding P, Lu B, Wu G, Ma X. LukS-PV inhibits the proliferation of hepatocellular carcinoma cells by maintaining FOXO3 stability via the PI3K/AKT signaling pathway. Cell Signal 2022;:110357. [PMID: 35589047 DOI: 10.1016/j.cellsig.2022.110357] [Reference Citation Analysis]
6 Zhang DD, Shi Y, Liu JB, Yang XL, Xin R, Wang HM, Wang PY, Jia CY, Zhang WJ, Ma YS, Fu D. Construction of a Myc-associated ceRNA network reveals a prognostic signature in hepatocellular carcinoma. Mol Ther Nucleic Acids 2021;24:1033-50. [PMID: 34141458 DOI: 10.1016/j.omtn.2021.04.019] [Reference Citation Analysis]
7 Ma F, Wang Z, Qiang Y, Xu L, Ding P, Wang Y, Ma X. LukS-PV Inhibits Hepatocellular Carcinoma Cells Migration via the TNNC1/PI3K/AKT Axis. Onco Targets Ther 2020;13:10221-30. [PMID: 33116603 DOI: 10.2147/OTT.S278540] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Wang Z, Yu W, Qiang Y, Ma F, Ding P, Wang Y. Clinicopathological features and prognostic significance of C5aR in human solid tumors: a Meta-analysis. BMC Cancer 2021;21:1136. [PMID: 34688269 DOI: 10.1186/s12885-021-08883-5] [Reference Citation Analysis]